-
1
-
-
79952232216
-
Global cancer statistics
-
PID: 21296855
-
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
-
(2011)
CA Cancer J Clin
, vol.61
, Issue.2
, pp. 69-90
-
-
Jemal, A.1
Bray, F.2
Center, M.M.3
Ferlay, J.4
Ward, E.5
Forman, D.6
-
2
-
-
0032522232
-
Hmg4, a new member of the Hmg1/2 gene family
-
COI: 1:CAS:528:DyaK1cXjtlWqsbg%3D, PID: 9598312
-
Vaccari T, Beltrame M, Ferrari S, Bianchi ME. Hmg4, a new member of the Hmg1/2 gene family. Genomics. 1998;49(2):247–52.
-
(1998)
Genomics
, vol.49
, Issue.2
, pp. 247-252
-
-
Vaccari, T.1
Beltrame, M.2
Ferrari, S.3
Bianchi, M.E.4
-
3
-
-
0037381254
-
HMGB proteins and gene expression
-
COI: 1:CAS:528:DC%2BD3sXisV2rtbs%3D, PID: 12672494
-
Agresti A, Bianchi ME. HMGB proteins and gene expression. Curr Opin Genet Dev. 2003;13(2):170–8.
-
(2003)
Curr Opin Genet Dev
, vol.13
, Issue.2
, pp. 170-178
-
-
Agresti, A.1
Bianchi, M.E.2
-
4
-
-
74549226503
-
HMGB proteins: interactions with DNA and chromatin
-
COI: 1:CAS:528:DC%2BC3cXpslWgtw%3D%3D, PID: 20123072
-
Stros M. HMGB proteins: interactions with DNA and chromatin. Biochim Biophys Acta. 2010;1799(1–2):101–13.
-
(2010)
Biochim Biophys Acta
, vol.1799
, Issue.1-2
, pp. 101-113
-
-
Stros, M.1
-
5
-
-
33748808696
-
Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation
-
COI: 1:CAS:528:DC%2BD28XpvFSlsLc%3D, PID: 16945912
-
Nemeth MJ, Kirby MR, Bodine DM. Hmgb3 regulates the balance between hematopoietic stem cell self-renewal and differentiation. Proc Natl Acad Sci USA. 2006;103(37):13783–8.
-
(2006)
Proc Natl Acad Sci USA
, vol.103
, Issue.37
, pp. 13783-13788
-
-
Nemeth, M.J.1
Kirby, M.R.2
Bodine, D.M.3
-
6
-
-
77949425444
-
NUP98-HMGB3: a novel oncogenic fusion
-
COI: 1:STN:280:DC%2BC3c7mvVentg%3D%3D, PID: 19956199
-
Petit A, Ragu C, Della-Valle V, Mozziconacci MJ, Lafage-Pochitaloff M, Soler G, et al. NUP98-HMGB3: a novel oncogenic fusion. Leukemia. 2010;24:654–8.
-
(2010)
Leukemia
, vol.24
, pp. 654-658
-
-
Petit, A.1
Ragu, C.2
Della-Valle, V.3
Mozziconacci, M.J.4
Lafage-Pochitaloff, M.5
Soler, G.6
-
7
-
-
77953818716
-
Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas
-
PID: 20579387
-
Bao G, Qiao Q, Zhao H, He X. Prognostic value of HMGB1 overexpression in resectable gastric adenocarcinomas. World J Surg Oncol. 2010;8:52.
-
(2010)
World J Surg Oncol
, vol.8
, pp. 52
-
-
Bao, G.1
Qiao, Q.2
Zhao, H.3
He, X.4
-
8
-
-
77949424325
-
Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype
-
COI: 1:CAS:528:DC%2BC3cXivFKgsLY%3D, PID: 20072147
-
Staal FJ, de Ridder D, Szczepanski T, Schonewille T, van der Linden EC, van Wering ER, et al. Genome-wide expression analysis of paired diagnosis-relapse samples in ALL indicates involvement of pathways related to DNA replication, cell cycle and DNA repair, independent of immune phenotype. Leukemia. 2010;24(3):491–9.
-
(2010)
Leukemia
, vol.24
, Issue.3
, pp. 491-499
-
-
Staal, F.J.1
de Ridder, D.2
Szczepanski, T.3
Schonewille, T.4
van der Linden, E.C.5
van Wering, E.R.6
-
9
-
-
84885432272
-
Prognostic value of HMGB3 expression in patients with non-small cell lung cancer
-
COI: 1:CAS:528:DC%2BC3sXhsFKqs7nI
-
Song N, Liu B, Jian-Ling W, Zhang R-F, Duan L, He W-S, et al. Prognostic value of HMGB3 expression in patients with non-small cell lung cancer. Tumor Biol. 2013;34(5):2599–603.
-
(2013)
Tumor Biol
, vol.34
, Issue.5
, pp. 2599-2603
-
-
Song, N.1
Liu, B.2
Jian-Ling, W.3
Zhang, R.-F.4
Duan, L.5
He, W.-S.6
-
10
-
-
84889570129
-
HMGB3 characterization in gastric cancer
-
COI: 1:CAS:528:DC%2BC2cXptFSltbw%3D, PID: 24338397
-
Gong Y, Cao Y, Song L, Zhou J, Wang C, Wu B. HMGB3 characterization in gastric cancer. Genet Mol Res. 2013;12(4):6032–9.
-
(2013)
Genet Mol Res
, vol.12
, Issue.4
, pp. 6032-6039
-
-
Gong, Y.1
Cao, Y.2
Song, L.3
Zhou, J.4
Wang, C.5
Wu, B.6
-
11
-
-
84884889399
-
Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation
-
COI: 1:CAS:528:DC%2BC3sXhsFyrurrF, PID: 24098490
-
Elgamal OA, Park JK, Gusev Y, Azevedo- Pouly AC, Jiang J, Roopra A, et al. Tumor suppressive function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS ONE. 2013;8(10):e76402.
-
(2013)
PLoS ONE
, vol.8
, Issue.10
, pp. e76402
-
-
Elgamal, O.A.1
Park, J.K.2
Gusev, Y.3
Azevedo- Pouly, A.C.4
Jiang, J.5
Roopra, A.6
-
12
-
-
33645321647
-
MicroRNAs in cell proliferation, cell death and tumorigenesis
-
COI: 1:CAS:528:DC%2BD28Xis1GktLc%3D, PID: 16495913
-
Hwang HW, Mendell JT. MicroRNAs in cell proliferation, cell death and tumorigenesis. Br J Cancer. 2006;94(6):776–80.
-
(2006)
Br J Cancer
, vol.94
, Issue.6
, pp. 776-780
-
-
Hwang, H.W.1
Mendell, J.T.2
-
13
-
-
77649312099
-
Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma
-
COI: 1:CAS:528:DC%2BC3cXhtFahtr%2FJ
-
Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer. 2010;9(16):1–10.
-
(2010)
Mol Cancer
, vol.9
, Issue.16
, pp. 1-10
-
-
Wan, H.Y.1
Guo, L.M.2
Liu, T.3
Liu, M.4
Li, X.5
Tang, H.6
-
14
-
-
24644446398
-
Ribo-gnome: the big world of small RNAs
-
COI: 1:CAS:528:DC%2BD2MXpsFWisrg%3D, PID: 16141061
-
Zamore PD, Haley B. Ribo-gnome: the big world of small RNAs. Science. 2005;309(5740):1519–24.
-
(2005)
Science
, vol.309
, Issue.5740
, pp. 1519-1524
-
-
Zamore, P.D.1
Haley, B.2
-
15
-
-
33646782348
-
Non-coding RNA
-
COI: 1:CAS:528:DC%2BD28XktlSisr4%3D, PID: 16651366
-
Mattick JS, Makunin IV. Non-coding RNA. Hum Mol Genet. 2006;15(Spec No 1):R17–29.
-
(2006)
Hum Mol Genet
, vol.15
, pp. R17-R29
-
-
Mattick, J.S.1
Makunin, I.V.2
-
16
-
-
77951846726
-
Identification of a new microRNA expression profile as a potential cancer screening tool
-
COI: 1:CAS:528:DC%2BC3cXhtlaktLnJ, PID: 20370992
-
Roa W, Brunet B, Guo L, Amanie J, Fairchild A, Gabos Z, et al. Identification of a new microRNA expression profile as a potential cancer screening tool. Clin Invest Med. 2010;33(2):E124.
-
(2010)
Clin Invest Med
, vol.33
, Issue.2
, pp. E124
-
-
Roa, W.1
Brunet, B.2
Guo, L.3
Amanie, J.4
Fairchild, A.5
Gabos, Z.6
-
17
-
-
84872374580
-
A set of specific miRNAs is connected with murine and human gastric cancer
-
COI: 1:CAS:528:DC%2BC38Xhs1ShtrnI
-
Shah AA, Leidinger P, Backes C, Keller A, Karpinski P, Sasiadek MM, et al. A set of specific miRNAs is connected with murine and human gastric cancer. Gene Chromosome Cancer. 2013;52(3):237–49.
-
(2013)
Gene Chromosome Cancer
, vol.52
, Issue.3
, pp. 237-249
-
-
Shah, A.A.1
Leidinger, P.2
Backes, C.3
Keller, A.4
Karpinski, P.5
Sasiadek, M.M.6
-
18
-
-
84884559285
-
Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray
-
Liu F, Xiong Y, Zhao Y, Tao L, Zhang Z, Zhang H, et al. Identification of aberrant microRNA expression pattern in pediatric gliomas by microarray. Diagn Pathol. 2013;8(158):1–10.
-
(2013)
Diagn Pathol
, vol.8
, Issue.158
, pp. 1-10
-
-
Liu, F.1
Xiong, Y.2
Zhao, Y.3
Tao, L.4
Zhang, Z.5
Zhang, H.6
-
19
-
-
31144445320
-
Incidence and mortality of gastric cancer in China
-
PID: 16440411
-
Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12(1):17–20.
-
(2006)
World J Gastroenterol
, vol.12
, Issue.1
, pp. 17-20
-
-
Yang, L.1
-
20
-
-
82955250119
-
Stomach—genetic and epigenetic alterations of preneoplastic and neoplastic lesions
-
PID: 22112492
-
David S, Meltzer SJ. Stomach—genetic and epigenetic alterations of preneoplastic and neoplastic lesions. Cancer Biomark. 2010;9(1–6):493–507.
-
(2010)
Cancer Biomark
, vol.9
, Issue.1-6
, pp. 493-507
-
-
David, S.1
Meltzer, S.J.2
-
21
-
-
77149174482
-
The microRNA network and tumor metastasis
-
COI: 1:CAS:528:DC%2BD1MXhsVGlur3F, PID: 19935707
-
Zhang H, Li Y, Lai M. The microRNA network and tumor metastasis. Oncogene. 2010;29(7):937–48.
-
(2010)
Oncogene
, vol.29
, Issue.7
, pp. 937-948
-
-
Zhang, H.1
Li, Y.2
Lai, M.3
-
22
-
-
78649263282
-
The redox protein HMGB1 regulates cell death and survival in cancer treatment
-
COI: 1:CAS:528:DC%2BC3cXhs1WltrnO, PID: 20861675
-
Tang D, Loze MT, Zeh HJ, Kang R. The redox protein HMGB1 regulates cell death and survival in cancer treatment. Autophagy. 2010;6(8):1181–3.
-
(2010)
Autophagy
, vol.6
, Issue.8
, pp. 1181-1183
-
-
Tang, D.1
Loze, M.T.2
Zeh, H.J.3
Kang, R.4
-
23
-
-
84862757453
-
High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer
-
COI: 1:CAS:528:DC%2BC38XlvFKgurg%3D, PID: 22484401
-
Chen J, Xi B, Zhao Y, Yu Y, Zhang J, Wang C. High-mobility group protein B1 (HMGB1) is a novel biomarker for human ovarian cancer. Gynecol Oncol. 2012;126(1):109–17.
-
(2012)
Gynecol Oncol
, vol.126
, Issue.1
, pp. 109-117
-
-
Chen, J.1
Xi, B.2
Zhao, Y.3
Yu, Y.4
Zhang, J.5
Wang, C.6
-
24
-
-
84855334252
-
Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells
-
COI: 1:CAS:528:DC%2BC3MXhsV2rsb3J, PID: 21953494
-
Song B, Song WG, Li ZJ, Xu ZF, Wang XW, Wang CX, et al. Effect of HMGB1 silencing on cell proliferation, invasion and apoptosis of MGC-803 gastric cancer cells. Cell Biochem Funct. 2011;30:11–7.
-
(2011)
Cell Biochem Funct
, vol.30
, pp. 11-17
-
-
Song, B.1
Song, W.G.2
Li, Z.J.3
Xu, Z.F.4
Wang, X.W.5
Wang, C.X.6
-
25
-
-
84884197810
-
High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma
-
Tang HR, Luo XQ, Xu G, Wang Y, Feng ZJ, Xu H, et al. High mobility group-box 3 overexpression is associated with poor prognosis of resected gastric adenocarcinoma. World J Gastroenterol. 2013;18(48):7319–26.
-
(2013)
World J Gastroenterol
, vol.18
, Issue.48
, pp. 7319-7326
-
-
Tang, H.R.1
Luo, X.Q.2
Xu, G.3
Wang, Y.4
Feng, Z.J.5
Xu, H.6
-
26
-
-
84899103912
-
Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology
-
PID: 24705787
-
Moser B, Janik S, Schiefer AI, Müllauer L, Bekos C, Scharrer A, et al. Expression of RAGE and HMGB1 in thymic epithelial tumors, thymic hyperplasia and regular thymic morphology. Plos One. 2014;9(4):e94118.
-
(2014)
Plos One
, vol.9
, Issue.4
, pp. e94118
-
-
Moser, B.1
Janik, S.2
Schiefer, A.I.3
Müllauer, L.4
Bekos, C.5
Scharrer, A.6
-
27
-
-
84876465381
-
MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1
-
COI: 1:CAS:528:DC%2BC3sXlsVGrtb0%3D, PID: 23523916
-
Qin W, Ren Q, Liu T, Huang Y, Wang J. MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1. FEBS Lett. 2013;587(9):1434–9.
-
(2013)
FEBS Lett
, vol.587
, Issue.9
, pp. 1434-1439
-
-
Qin, W.1
Ren, Q.2
Liu, T.3
Huang, Y.4
Wang, J.5
-
28
-
-
84876493330
-
MiR-449c targets c-myc and inhibits NSCLC cell progression
-
COI: 1:CAS:528:DC%2BC3sXltFCmu74%3D, PID: 23507140
-
Miao LJ, Huang SF, Sun ZT, Gao ZY, Zhang RX, Liu Y, et al. MiR-449c targets c-myc and inhibits NSCLC cell progression. FEBS Lett. 2013;587(9):1359–65.
-
(2013)
FEBS Lett
, vol.587
, Issue.9
, pp. 1359-1365
-
-
Miao, L.J.1
Huang, S.F.2
Sun, Z.T.3
Gao, Z.Y.4
Zhang, R.X.5
Liu, Y.6
-
29
-
-
84867576424
-
miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells
-
COI: 1:CAS:528:DC%2BC38XhsVamu7fM, PID: 23010597
-
Li J, Wang Y, Luo J, Fu Z, Ying J, Yu Y, et al. miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells. FEBS Lett. 2012;586(20):3761–5.
-
(2012)
FEBS Lett
, vol.586
, Issue.20
, pp. 3761-3765
-
-
Li, J.1
Wang, Y.2
Luo, J.3
Fu, Z.4
Ying, J.5
Yu, Y.6
-
30
-
-
84865083963
-
Hmgb3 is regulated by MicroRNA-206 during muscle
-
COI: 1:CAS:528:DC%2BC38Xht1CnsbzI, PID: 22912879
-
Maciotta S, Meregalli M, Cassinelli L, Parolini D, Farini A, Fraro GD, et al. Hmgb3 is regulated by MicroRNA-206 during muscle. PLoS ONE. 2012;7(8):e43464.
-
(2012)
PLoS ONE
, vol.7
, Issue.8
, pp. e43464
-
-
Maciotta, S.1
Meregalli, M.2
Cassinelli, L.3
Parolini, D.4
Farini, A.5
Fraro, G.D.6
|